China’s Clover Biopharmaceuticals Ltd. (02197.HK) was finally looking to the future after a big bet on Covid vaccines failed to pay off. However, decisions made early on in the pandemic are still ...

世界卫生组织日前宣布，中国通过疫苗国家监管体系评估。世界卫生组织对疫苗国家监管体系的评估，是一项世界公认的、可以科学全面评估一个国家疫苗监管水平的国际考核。我国的疫苗监管体系已于2011年、2014年先后两次通过评估。 China's vaccine regulatory system has passed an assessment by the World Health ...

每日一词∣新冠疫苗知识产权豁免 waiver of COVID-19 vaccine patents 中国日报网 2022-06-22 17:00 ...

China announced on May 2020 that it would make COVID-19 vaccines a global public good in order to ensure vaccine accessibility and affordability in the developing world. By far, the country has ...

'WTO approves vaccine-patent waiver to help combat Covid-19 pandemic', 17 June 2022 "The World Trade Organisation (WTO) approved a politically important deal on Friday (June 17) to water down ...

无专利“纯素”新冠疫苗问世 有望改变全球抗疫格局 COVID-19 Tue 1 Mar 2022 ...

'Rich countries must stop blocking the COVID vaccine patent waiver', 30 November 2021 "The COVID-19 crisis and measures taken by states to mitigate, prevent and contain the spread of the virus have ...

（点击封面图片，收听完整音频） 2020年10月，印度和南非提议世贸组织（WTO）将COVID-19疫苗的知识产权暂停数年，以帮助加快疫苗的生产和分配。

为了确保每个国家都能获得我们的COVID-19疫苗，我们必须做到两点：给出所有人都能负担得起的价格；制造可靠的、足够的疫苗。

到目前为止，疫苗绝大多数流向较富裕的国家，富裕国家在今年早些时候为其争取了合同。富裕国家的新冠肺炎感染率随着今年疫苗接种率的上升而 ...